Mindfully Curated
After months of hard work from the eth2 research team, along with Consensys and DeepWork Studio, we’re happy to announce the release of the eth2 validator launchpad (testnet version). We’re releasing it now so that you can keep track of, and make depo…
Testnets, testnets, testnets! tl;dr Medalla multi-client testnet launch date set 🚀 Initial beta attacknets are up. Calling all whitehats 👩‍🍳 Exciting progress on the eth1+eth2 merger đź‘Š Medalla testnet Following the excellent stability of Altona and…
After decades of spectacular success in winning over developers, Intel’s x86 platform now risks losing them to Apple and Amazon.
After decades of spectacular success in winning over developers, Intel’s x86 platform now risks losing them to Apple and Amazon.
Some may characterize robots as replacing human jobs, those with more foresight see the innovation they can bring to small and big businesses alike.
Some may characterize robots as replacing human jobs, those with more foresight see the innovation they can bring to small and big businesses alike.
The July mARKet update is an innovation-focused webinar. This month’s spotlight: V-Shaped Recovery, Inflation vs. Deflation, Value vs. Growth, Valuations…
The July mARKet update is an innovation-focused webinar. This month’s spotlight: V-Shaped Recovery, Inflation vs. Deflation, Value vs. Growth, Valuations…
\This is part #1 of a series where anyone can ask questions about Geth and I’ll attempt to answer the highest voted one each week with a mini writeup. This week’s highest voted question was: Could you share how the flat db structure is different from t…
Preparation is key.
Genomics innovation, ushering in the "genomic age" of medicine, promises profound ramifications for human health and for the companies involved.
ARK believes investors need to understand how genomics innovation can be a catalyst for growth. Download the latest white paper exploring the genomic age.
Without a steady battery supply chain for EVs, the technology couldn’t take off. We talked to Simon Moores & Vivas Kumar from Benchmark Mineral Intelligence
Genomics innovation, ushering in the “genomic age” of medicine, promises profound ramifications for human health and for the companies involved.
ARK believes investors need to understand how genomics innovation can be a catalyst for growth. Download the latest white paper exploring the genomic age.
Without a steady battery supply chain for EVs, the technology couldn’t take off. We talked to Simon Moores & Vivas Kumar from Benchmark Mineral Intelligence